查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1790292

细胞和基因疗法临床试验市场规模、份额和趋势分析报告：按阶段、适应症、地区和细分市场预测，2025 年至 2033 年

Cell And Gene Therapy Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III), By Indication (Oncology, Cardiology, CNS, Musculoskeletal, Infectious Diseases), By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

细胞与基因治疗临床试验市场摘要

市场的主要驱动力在于基因医学技术创新的加速以及对先进疗法监管支持的不断加强。 CRISPR 等基因组编辑技术的进展，以及病毒和非病毒载体递送系统的突破，使研究人员能够开发针对罕见遗传疾病、癌症和自体免疫疾病的高度标靶化候选治疗药物。 FDA 和 EMA 等监管机构推出了加速核准途径、孤儿药资格认定和再生医学先进疗法 (RMAT) 资格认定，以支持 CGT 的开发。这些激励措施显着减轻了开发新型 CGT 产品的公司的时间和成本负担，并鼓励进行早期试验。

此外，资本的涌入以及专注于CGT开发的生物技术公司、大型製药公司和学术研究中心之间的策略联盟正在推动市场发展。这种资金势头，尤其是来自创业投资和公私合营关係的资金，使临床试验申办方能够从初步试验扩展到多中心国际试验。 Bluebird Bio、CRISPR Therapeutics和Beam Therapeutics等公司已在镰状细胞疾病、CAR-T疗法和基于基因编辑的肿瘤学研发管线等领域启动了多项I/II期试验。此外，检验这些治疗方法的安全性、剂量和长期疗效的需求，也推动了对专门的CRO和针对CGT试验的测试基础设施的需求。

目录

第一章调查方法与范围

第二章执行摘要

第三章细胞和基因治疗临床试验市场：变数、趋势和范围

  • 市场体系展望
  • 细胞与基因治疗临床试验市场动态
  • 技术格局
  • 定价模式分析
  • 细胞与基因治疗临床试验市场：分析工具

第四章：细胞和基因治疗临床试验市场：各阶段的估计和趋势分析

  • 细分仪表板
  • 全球细胞和基因治疗临床试验市场分阶段波动分析
  • 全球细胞基因治疗临床试验市场规模及趋势分析（分阶段，2021-2033）
  • 第一阶段
  • 第二阶段
  • 第三阶段
  • 第四阶段

第五章：细胞和基因治疗临床试验市场：按适应症的估计和趋势分析

  • 细分仪表板
  • 全球细胞和基因治疗临床试验市场按适应症波动分析
  • 全球细胞和基因疗法临床试验市场规模和趋势分析（按适应症，2021-2033 年）
  • 肿瘤学
  • 心臟病学
  • 中枢神经系统
  • 肌肉骨骼
  • 感染疾病
  • 皮肤科
  • 内分泌学、代谢和遗传学
  • 免疫学和炎症
  • 眼科
  • 血液学
  • 胃肠病学
  • 其他的

6. 细胞和基因疗法临床试验市场：按类型、产品、测试、样本和最终用途的区域估计和趋势分析

  • 区域市场仪表板
  • 全球区域市场概况
  • 市场规模、预测趋势分析，2021-2033年：
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争态势

  • 公司分类
  • 细胞与基因治疗临床试验市场占有率分析（2024年）
  • 公司简介
    • IQVIA
    • ICON Plc
    • LabCorp
    • Charles River Laboratories
    • PAREXEL International Corp.
    • Syneos Health
    • Medpace
    • Thermo Fisher Scientific, Inc.
    • Novotech
    • Veristat, LLC
Product Code: GVR-4-68039-409-7

Cell And Gene Therapy Clinical Trials Market Summary

The market is primarily driven by the accelerating pace of innovation in genetic medicine and increasing regulatory support for advanced therapies. Advancements in genome editing technologies such as CRISPR, as well as breakthroughs in viral and non-viral vector delivery systems, have enabled researchers to develop highly targeted therapeutic candidates for rare genetic disorders, cancers, and autoimmune diseases. Regulatory bodies, including the FDA and EMA, have introduced accelerated approval pathways, orphan drug designations, and RMAT (Regenerative Medicine Advanced Therapy) designations to support CGT development. These incentives have significantly reduced the time and cost burden for companies developing novel CGT products, encouraging the launch of early-phase trials.

Furthermore, the influx of funding and strategic partnerships between biotech firms, large pharmaceutical companies, and academic research centers focused on CGT development is driving the market growth. This financial momentum, especially from venture capital and public-private collaborations, is enabling clinical trial sponsors to scale up from pilot studies to multi-site international trials. Companies like Bluebird Bio, CRISPR Therapeutics, and Beam Therapeutics, numerous Phase I/II trials are being initiated in areas such as sickle cell disease, CAR-T therapies, and gene editing-based oncology pipelines.Moreover, the need to validate safety, dosing, and long-term efficacy of these therapies has increased demand for specialized CROs and trial infrastructure tailored to CGT studies.

Global Cell And Gene Therapy Clinical Trials Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global cell and gene therapy clinical trials market report based on phase, indication, and region:

  • Phase Outlook (Revenue, USD Million, 2021 - 2033)
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Indication Outlook (Revenue, USD Million, 2021 - 2033)
  • Oncology
  • Cardiology
  • CNS
  • Musculoskeletal
  • Infectious diseases
  • Dermatology
  • Endocrine, metabolic, genetic
  • Immunology & inflammation
  • Ophthalmology
  • Hematology
  • Gastroenterology
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Norway
    • Sweden
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Value chain based analysis (Model 2)
    • 1.7.3. Multivariate Analysis (Model 3)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Cell And Gene Therapy Clinical Trials Market: Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Cell And Gene Therapy Clinical Trials Market Dynamics
    • 3.2.1. Market Driver Impact Analysis
      • 3.2.1.1. Growing Interest in Cell and Gene Therapy
      • 3.2.1.2. Adoption Of New Technology in Clinical Research
      • 3.2.1.3. Increasing Investments And R&D Funding
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Recruitment Obstacles
  • 3.3. Technological Landscape
  • 3.4. Pricing Model Analysis
  • 3.5. Cell And Gene Therapy Clinical Trials Market: Analysis Tools
    • 3.5.1. Porter's Five Forces Analysis
    • 3.5.2. PESTEL Analysis

Chapter 4. Cell And Gene Therapy Clinical Trials Market: Phase Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Cell and Gene Therapy Clinical Trials Market Phase Movement Analysis
  • 4.3. Global Cell and Gene Therapy Clinical Trials Market Size & Trend Analysis, by Phase, 2021 to 2033 (USD Million)
  • 4.4. Phase I
    • 4.4.1. Phase I Market Estimates and Forecasts, 2021 - 2033 (USD million)
  • 4.5. Phase II
    • 4.5.1. Phase II Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Phase III
    • 4.6.1. Phase III Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Phase IV
    • 4.7.1. Phase IV Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Cell And Gene Therapy Clinical Trials Market: Indication Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Cell and Gene Therapy Clinical Trials Market Indication Movement Analysis
  • 5.3. Global Cell and Gene Therapy Clinical Trials Market Size & Trend Analysis, by Indication, 2021 to 2033 (USD Million)
  • 5.4. Oncology
    • 5.4.1. Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Cardiology
    • 5.5.1. Cardiology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. CNS
    • 5.6.1. CNS Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Musculoskeletal
    • 5.7.1. Musculoskeletal Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Infectious diseases
    • 5.8.1. Infectious diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.9. Dermatology
    • 5.9.1. Dermatology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.10. Endocrine, metabolic, genetic
    • 5.10.1. Endocrine, metabolic, genetic Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.11. Immunology & inflammation
    • 5.11.1. Immunology & inflammation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.12. Ophthalmology
    • 5.12.1. Ophthalmology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.13. Hematology
    • 5.13.1. Hematology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.14. Gastroenterology
    • 5.14.1. Gastroenterology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.15. Others
    • 5.15.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Cell And Gene Therapy Clinical Trials Market: Regional Estimates & Trend Analysis by Type, Product, Test, Sample, End Use

  • 6.1. Regional Market Dashboard
  • 6.2. Global Regional Market Snapshot
  • 6.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 6.4. North America
    • 6.4.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Competitive Scenario
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Europe
    • 6.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Competitive Scenario
      • 6.5.5.3. Regulatory Framework
      • 6.5.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Competitive Scenario
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.7. Denmark
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Competitive Scenario
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.8. Sweden
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Competitive Scenario
      • 6.5.8.3. Regulatory Framework
      • 6.5.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.9. Norway
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Competitive Scenario
      • 6.5.9.3. Regulatory Framework
      • 6.5.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Competitive Scenario
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.5. Australia
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Competitive Scenario
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.6. South Korea
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Competitive Scenario
      • 6.6.6.3. Regulatory Framework
      • 6.6.6.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Competitive Scenario
      • 6.6.7.3. Regulatory Framework
      • 6.6.7.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. MEA
    • 6.8.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Competitive Scenario
      • 6.8.2.3. Regulatory Framework
      • 6.8.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Competitive Scenario
      • 6.8.3.3. Regulatory Framework
      • 6.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Competitive Scenario
      • 6.8.4.3. Regulatory Framework
      • 6.8.4.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Competitive Scenario
      • 6.8.5.3. Regulatory Framework
      • 6.8.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Cell And Gene Therapy Clinical Trials Market Share Analysis, 2024
  • 7.3. Company Profiles
    • 7.3.1. IQVIA
      • 7.3.1.1. Company overview
      • 7.3.1.2. Financial performance
      • 7.3.1.3. Product benchmarking
      • 7.3.1.4. Strategic initiatives
    • 7.3.2. ICON Plc
      • 7.3.2.1. Company overview
      • 7.3.2.2. Financial performance
      • 7.3.2.3. Product benchmarking
      • 7.3.2.4. Strategic initiatives
    • 7.3.3. LabCorp
      • 7.3.3.1. Company overview
      • 7.3.3.2. Financial performance
      • 7.3.3.3. Product benchmarking
      • 7.3.3.4. Strategic initiatives
    • 7.3.4. Charles River Laboratories
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. PAREXEL International Corp.
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Syneos Health
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Medpace
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Thermo Fisher Scientific, Inc.
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Novotech
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Veristat, LLC
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America Cell and Gene Therapy Clinical Trials market estimates and forecasts, by region, 2021 - 2033 (USD Million)
  • Table 3 North America Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 4 North America Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 5 U.S. Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 6 U.S. Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 7 Canada Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 8 Canada Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 9 Mexico Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 10 Mexico Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 11 Europe Cell and Gene Therapy Clinical Trials market estimates and forecasts, by region, 2021 - 2033 (USD Million)
  • Table 12 Europe Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 13 Europe Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 14 UK Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 15 UK Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 16 Germany Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 17 Germany Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 18 France Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 19 France Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 20 Italy Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 21 Italy Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 22 Spain Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 23 Spain Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 24 Norway Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 25 Norway Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 26 Denmark Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 27 Denmark Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 28 Sweden Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 29 Sweden Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 30 Asia Pacific Cell and Gene Therapy Clinical Trials market estimates and forecasts, by region, 2021 - 2033 (USD Million)
  • Table 31 Japan Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 32 Japan Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 33 China Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 34 China Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 35 India Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 36 India Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 37 Australia Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 38 Australia Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 39 South Korea Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 40 South Korea Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 41 Thailand Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 42 Thailand Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 43 Latin America Cell and Gene Therapy Clinical Trials market estimates and forecasts, by region, 2021 - 2033 (USD Million)
  • Table 44 Latin America Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 45 Latin America Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 46 Brazil Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 47 Brazil Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 48 Argentina Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 49 Argentina Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 50 MEA Cell and Gene Therapy Clinical Trials market estimates and forecasts, by region, 2021 - 2033 (USD Million)
  • Table 51 MEA Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 52 MEA Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 53 South Africa Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 54 South Africa Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 55 Saudi Arabia Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 56 Saudi Arabia Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 57 Kuwait Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 58 Kuwait Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 59 UAE Cell and Gene Therapy Clinical Trials market estimates and forecasts, by phase, 2021 - 2033 (USD Million)
  • Table 60 UAE Cell and Gene Therapy Clinical Trials market estimates and forecasts, by indication, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Cell And Gene Therapy Clinical Trials market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Commodity flow analysis
  • Fig. 8 Value-Chain-Based Sizing & Forecasting
  • Fig. 9 QFD model sizing & forecasting
  • Fig. 10 Bottom-up approach
  • Fig. 11 Market snapshot
  • Fig. 12 Segment snapshot
  • Fig. 13 Segment snapshot
  • Fig. 14 Segment snapshot
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Parent market outlook, 2024 (USD Million)
  • Fig. 17 Ancillary market outlook, 2024 (USD Million)
  • Fig. 18 Cell And Gene Therapy Clinical Trials market dynamics
  • Fig. 19 Total R&D drug pipeline size, 2021 - 2024
  • Fig. 20 Total drug pipeline by development phase, 2024
  • Fig. 21 Porter's five forces analysis
  • Fig. 22 PESTEL analysis
  • Fig. 23 Cell And Gene Therapy Clinical Trials market phase outlook: Segment dashboard
  • Fig. 24 Cell And Gene Therapy Clinical Trials market, by phase segment: Market share, 2025 & 2033
  • Fig. 25 Phase I market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Phase II market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Phase III market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Phase IV market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Cell And Gene Therapy Clinical Trials market indication outlook: Segment dashboard
  • Fig. 30 Cell And Gene Therapy Clinical Trials market, by indication segment: Market share, 2024 & 2033
  • Fig. 31 Oncology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Cardiology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 CNS market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Musculoskeletal market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Infectious diseases market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Dermatology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Endocrine, metabolic, genetic market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Immunology & inflammation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Ophthalmology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Hematology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Gastroenterology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Regional market: Key takeaways
  • Fig. 44 Regional marketplace: Key takeaways
  • Fig. 45 North America Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 U S Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 Canada Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Mexico Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Europe Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 UK Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Germany Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 France Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Italy Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Spain Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Denmark Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Norway Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Sweden Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Asia Pacific Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Japan Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 China Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 India Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Australia Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 South Korea Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Thailand Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 82 Latin America Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 Brazil Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Argentina Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 87 MEA Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 South Africa Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 Saudi Arabia Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 Kuwait Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 UAE Cell and Gene Therapy Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 96 Market participant categorization
  • Fig. 97 Heat map analysis